258 related articles for article (PubMed ID: 37138298)
1. Uncovering the gray zone: mapping the global landscape of direct-to-consumer businesses offering interventions based on secretomes, extracellular vesicles, and exosomes.
Asadpour A; Yahaya BH; Bicknell K; Cottrell GS; Widera D
Stem Cell Res Ther; 2023 May; 14(1):111. PubMed ID: 37138298
[TBL] [Abstract][Full Text] [Related]
2. Direct-to-consumer marketing of stem cell interventions by Canadian businesses.
Turner L
Regen Med; 2018 Sep; 13(6):643-658. PubMed ID: 30255734
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications.
Gemayel J; Chaker D; El Hachem G; Mhanna M; Salemeh R; Hanna C; Harb F; Ibrahim A; Chebly A; Khalil C
Clin Transl Oncol; 2023 Jul; 25(7):2056-2068. PubMed ID: 36808392
[TBL] [Abstract][Full Text] [Related]
4. Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies.
Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC
Regen Med; 2023 Nov; 18(11):857-868. PubMed ID: 37867326
[No Abstract] [Full Text] [Related]
5. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies.
Turner L; Martinez JR; Najjar S; Arachchilage TR; Sahrai V; Wang JC
Regen Med; 2023 Oct; 18(10):781-793. PubMed ID: 37795701
[No Abstract] [Full Text] [Related]
6. The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine.
Rahimi B; Panahi M; Saraygord-Afshari N; Taheri N; Bilici M; Jafari D; Alizadeh E
Mol Biol Rep; 2021 Jul; 48(7):5607-5619. PubMed ID: 34191238
[TBL] [Abstract][Full Text] [Related]
7. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era.
Turner L; Wang JC; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Sahrai V
Cytotherapy; 2024 Apr; 26(4):393-403. PubMed ID: 38340106
[TBL] [Abstract][Full Text] [Related]
8. Beyond "medical tourism": Canadian companies marketing medical travel.
Turner L
Global Health; 2012 Jun; 8():16. PubMed ID: 22703873
[TBL] [Abstract][Full Text] [Related]
9. Assessing "Cell Therapy" Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States.
Nirwan RS; Albini TA; Sridhar J; Flynn HW; Kuriyan AE
Ophthalmology; 2019 Oct; 126(10):1350-1355. PubMed ID: 30904542
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles Isolated from Mesenchymal Stromal Cells Primed with Hypoxia: Novel Strategy in Regenerative Medicine.
Pendse S; Kale V; Vaidya A
Curr Stem Cell Res Ther; 2021; 16(3):243-261. PubMed ID: 32957892
[TBL] [Abstract][Full Text] [Related]
11. Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims.
Turner L; Martinez JR; Najjar S; Rajapaksha Arachchilage T; Wang JC
Stem Cell Reports; 2023 Nov; 18(11):2010-2015. PubMed ID: 37890484
[TBL] [Abstract][Full Text] [Related]
12. Dental Mesenchymal Stem Cell Secretome: An Intriguing Approach for Neuroprotection and Neuroregeneration.
Gugliandolo A; Mazzon E
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008878
[TBL] [Abstract][Full Text] [Related]
13. Online marketing practices of regenerative medicine clinics in US-Mexico border region: a web surveillance study.
Chavez J; Shah NA; Ruoss S; Cuomo RE; Ward SR; Mackey TK
Stem Cell Res Ther; 2021 Mar; 12(1):189. PubMed ID: 33736697
[TBL] [Abstract][Full Text] [Related]
14. Secretome of Stem Cells: Roles of Extracellular Vesicles in Diseases, Stemness, Differentiation, and Reprogramming.
Kim HJ; Kim G; Lee J; Lee Y; Kim JH
Tissue Eng Regen Med; 2022 Feb; 19(1):19-33. PubMed ID: 34817808
[TBL] [Abstract][Full Text] [Related]
15. Canadian medical tourism companies that have exited the marketplace: Content analysis of websites used to market transnational medical travel.
Turner L
Global Health; 2011 Oct; 7():40. PubMed ID: 21995598
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products.
Laggner M; Gugerell A; Bachmann C; Hofbauer H; Vorstandlechner V; Seibold M; Gouya Lechner G; Peterbauer A; Madlener S; Demyanets S; Sorgenfrey D; Ostler T; Erb M; Mildner M; Ankersmit HJ
Stem Cell Res Ther; 2020 Jan; 11(1):9. PubMed ID: 31900195
[TBL] [Abstract][Full Text] [Related]
17. Adipose-Derived Stem Cells Secretome and Its Potential Application in "Stem Cell-Free Therapy".
Trzyna A; Banaś-Ząbczyk A
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34199330
[TBL] [Abstract][Full Text] [Related]
18. Exosomes and soluble secretome from hormone-treated endometrial epithelial cells direct embryo implantation.
Gurung S; Greening DW; Catt S; Salamonsen L; Evans J
Mol Hum Reprod; 2020 Jul; 26(7):510-520. PubMed ID: 32402079
[TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical application.
Noor Azlan NAB; Vitus V; Nor Rashid N; Nordin F; Tye GJ; Wan Kamarul Zaman WS
Cell Tissue Res; 2024 Mar; 395(3):227-250. PubMed ID: 38244032
[TBL] [Abstract][Full Text] [Related]
20. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.
Murdoch B; Zarzeczny A; Caulfield T
BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
